$13.71
0.191.37%
Last update: Jun 8, 3:41 PM
Relay Therapeutics Inc Earnings Estimates
RLAYNASDAQ
Relay Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:RLAY
Relay Therapeutics (RLAY) is scheduled to report Q2 earnings on August 6, 2026. Analysts estimate EPS of $-0.41 and quarterly revenue of $882.36K.
In the most recent quarter (Q1), Relay Therapeutics reported EPS of $-0.41, missing estimates of $-0.36 by 0.14%. Revenue came in at $3.00M, missing the estimate of $6.79M by 0.56%.
Over the last 4 quarters, Relay Therapeutics has averaged an EPS surprise of 0.13% and a revenue surprise of 0.88%.
Earnings Date
Aug 6
EPS Estimate
$-0.410
Quarterly Revenue Estimate
$882.36K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$10.68M
Relay Therapeutics Earnings History
Analyze the earnings history of Relay Therapeutics using advanced sorting and filters.
Loading calendar...
Relay Therapeutics (RLAY) Earnings Per Share
The chart below shows Relay Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Relay Therapeutics (RLAY) Revenue
The chart below shows Relay Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Relay Therapeutics (NASDAQ:RLAY) reporting earnings?
Relay Therapeutics (RLAY) is scheduled to report earnings on August 6, 2026. The last reported earnings were for reported on May 5, 2026 for Q1.
What were the latest earnings per share (EPS) for Relay Therapeutics (NASDAQ:RLAY)?
The Actual EPS was $-0.41, which missed the estimate of $-0.36.
What were Relay Therapeutics’s (NASDAQ:RLAY) revenues?
The Actual Revenue was $3.00M, which missed the estimate of $6.79M.
